Thanks for side posting. Attempting to get this to the individuals in the labs, off network.

Vaccine is near impossible due to mutagenic properties.

Posting this to add to the pool, but outside the network.

I have no need for personal gain, this is to assist only.


If you will recall, there was a series of studies conducted in 2014-2016 on various pathogens.

The treatment protocol was not vaccination/antibody in origin. It was holistic and multifaceted.



The treatment focus was on Ebola EBV/Lassa LHF
Protocol was three fold and as follows:

1) Binding agent to viral specific genetic attachments.
IE Zinc "feelers" to read host genetic code for this pathogen.

2) Delivery of protein coat dissolving agent for viral shell.

3) Anti Malarial chemicals to destroy replication coding in center of viral core.



It is an easy compound to manufacture, given its not centrifuge dependent and can be delivered in saline suspension. Very easily sourced substances in comparison to HIV drugs.

Broad spectrum plasma diffusion for direct antiviral load application.